Medicaid coverage was linked to “substantially reduced” depression and the increased diagnosis of diabetes and the use of diabetes medication among low-income adults. At the same time, Medicaid coverage had no detectable effect on the prevalence of diabetes, high cholesterol, or high blood pressure, according to the study published in the May 2 issue of The New England Journal of Medicine.
Regardless of its status as an herbal dietary supplement, St. John's Wort is a drug
Ruling clears obstacles judge said were politically influenced
The IMS report tracked impact of care on Managed Medicaid beneficiaries in Kentucky, New Jersey, New York, and Ohio since 2011 in three therapeutic areas: antipsychotics, diabetes agents, and respiratory medications
Restrictive state Medicaid policies are delaying care because of cost and should be reconsidered, according to a recent NEJM letter to the editor.
This week an Oklahoma House committee voted 7 to 3 in favor of giving the State Board of Pharmacy the power to regulate pharmacy benefit managers (PBMs).